Posts by Sichenzia Ross Ference LLP
Sichenzia Ross Ference LLP Represents Sunshine Biopharma, Inc. in $5.0 Million Private Placement Priced At-the-Market
Sichenzia Ross Ference LLP Represents Lexaria Bioscience Corp. in $2.0 Million Public Offering
Sichenzia Ross Ference LLP Names Owen A. Kloter as Partner
Press Release – New York, NY– May 11, 2023 – The law firm of Sichenzia Ross Ference LLP today announced the promotion of Owen Kloter to partner. “The Firm is excited to announce that Owen Kloter has been named a partner of the Firm. During the seven years that Owen has been part of the…
Read MoreSichenzia Ross Ference LLP Represents Zynex, Inc. in $60 Million 144A Private Offering of Convertible Notes
Sichenzia Ross Ference LLP 代表 Zynex, Inc. 进行 6000 万美元的 144A 可转换票据私募发行
Sichenzia Ross Ference LLP Represents Wang & Lee Group, Inc. in $8 Million Initial Public Offering of Ordinary Shares
CMF Represents Spartan Capital Securities LLC In $1.35 Million Underwritten Confidentially Marketed Public Offering Of Cel-Sci Common Stock
Understanding the Differences Between NQSOs and ISOs: A Guide for Companies
Stock option plans can be a valuable tool for companies to attract and retain talented employees, consultants, and other non-employee service providers. When implementing a stock option plan, it is important to understand the differences between Non-Qualified Stock Options (NQSOs) and Incentive Stock Options (ISOs) to determine which option is best suited for your company’s…
Read MoreSichenzia Ross Ference LLP Represents Boustead Securities, LLC in $5.12 Million Initial Public Offering of Ordinary Shares of VCI Global Limited
Sichenzia Ross Ference LLP Represents Revere Securities, LLC in a $5 Million Initial Public Offering of Ordinary Shares of Millennium Group International Holdings Ltd
